litlas
Log inCreate account

Flavio Vincenti

Active 1979–2026

100
Papers
20,080
Citations
76
h-index
96
i10-index

Citations

Citations per year for Flavio Vincenti1982: 1 citations1983: 3 citations1984: 1 citations1985: 3 citations1986: 7 citations1987: 5 citations1988: 7 citations1989: 1 citations1990: 6 citations1991: 6 citations1992: 8 citations1993: 11 citations1994: 5 citations1995: 11 citations1996: 16 citations1997: 32 citations1998: 46 citations1999: 65 citations2000: 41 citations2001: 68 citations2002: 69 citations2003: 63 citations2004: 100 citations2005: 80 citations2006: 71 citations2007: 79 citations2008: 83 citations2009: 131 citations2010: 145 citations2011: 145 citations2012: 129 citations2013: 146 citations2014: 144 citations2015: 112 citations2016: 145 citations2017: 117 citations2018: 78 citations2019: 435 citations2020: 438 citations2021: 384 citations2022: 280 citations2023: 202 citations2024: 358 citations2025: 196 citations2026: 6 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,545 citing papers, 30% of this breakdownGermany: 336 citing papers, 6.5% of this breakdownFrance: 321 citing papers, 6.2% of this breakdownUnited Kingdom: 318 citing papers, 6.2% of this breakdownCanada: 247 citing papers, 4.8% of this breakdownItaly: 241 citing papers, 4.7% of this breakdownChina: 233 citing papers, 4.5% of this breakdownNetherlands: 206 citing papers, 4% of this breakdownSpain: 194 citing papers, 3.8% of this breakdownAustralia: 181 citing papers, 3.5% of this breakdownBelgium: 150 citing papers, 2.9% of this breakdownSwitzerland: 121 citing papers, 2.3% of this breakdown
0%30%Other 20.6%

Institutions

Fields

  • Medicine82.4%
  • Immunology and Microbiology8.9%
  • Biochemistry, Genetics and Molecular Biology7%
  • Agricultural and Biological Sciences0.3%
  • Health Professions0.3%
  • Neuroscience0.2%
  • Other0.9%

Topics

  • Renal Transplantation Outcomes and Treatments14.6%
  • Transplantation: Methods and Outcomes4.4%
  • Renal Diseases and Glomerulopathies4.2%
  • Organ Transplantation Techniques and Outcomes3.9%
  • T-cell and B-cell Immunology3.4%
  • Cytomegalovirus and herpesvirus research3.3%
  • Other66.2%

Coauthors

All papers

Open in search
  1. Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients

    Authors: Ajit P. Limaye, Klemens Budde, Atul Humar, Flavio Vincenti, Dirk Kuypers, Robert Carroll, Nicole Stauffer, Yoshihiko Murata, Julie Strizki, Valerie Teal, Christopher L. Gilbert, Barbara Haber - JAMA 2023 cited by 188

  2. Belatacept and Long-Term Outcomes in Kidney Transplantation

    Authors: Flavio Vincenti, Lionel Rostaing, J.M. Boria Grinyo, Kim Rice, Steven Steinberg, Luis Gaite, Marie‐Christine Moal, Guillermo Mondragón-Ramírez, Jatin Kothari, Martin S. Polinsky, Herwig‐Ulf Meier‐Kriesche, Stéphane Munier, Christian P. Larsen - New England Journal of Medicine 2016 cited by 759

  3. A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

    Authors: Flavio Vincenti, B Charpentier, Yves Vanrenterghem, Lionel Rostaing, Barbara A. Bresnahan, P. Darji, P. Massari, G. Mondragon-Ramirez, Mamta Agarwal, G. Russo, C.‐S. Lin, Pushkal Garg, Christian P. Larsen - American Journal of Transplantation 2010 cited by 946

  4. Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses

    Authors: Meixue Duan, Doan C. Nguyen, Chester J. Joyner, Celia L. Saney, Christopher M. Tipton, Joel Andrews, Sagar Lonial, Caroline Kim, Ian Hentenaar, Astrid Kosters, Eliver Ghosn, Annette M. Jackson, Stuart J. Knechtle, Stalinraja Maruthamuthu, Sindhu Chandran, Tom Martin, Raja Rajalingam, Flavio Vincenti, Cynthia Breeden, Igñacio Sanz, Greg Gibson, F. Eun‐Hyung Lee - Cell Reports 2023 cited by 74

  5. Conversion from Calcineurin Inhibitor– to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial

    Authors: Klemens Budde, Rohini Prashar, Hermann Haller, M.C. Rial, Nassim Kamar, Avinash Kumar Ágarwal, Johan W. de Fijter, Lionel Rostaing, Stefan P. Berger, Arjang Djamali, Nicolae Leca, Lisa Allamassey, Sheng Gao, Martin S. Polinsky, Flavio Vincenti - Journal of the American Society of Nephrology 2021 cited by 99

  6. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary

    Authors: Bertram L. Kasiske, Martin Zeier, Jeremy R. Chapman, Jonathan C. Craig, Henrik Ekberg, Catherine Garvey, Michael D. Green, Vivekanand Jha, Michelle A. Josephson, Bryce Kiberd, Henri Kreis, Ruth A. McDonald, John M. Newmann, Gregorio T. Obrador, Flavio Vincenti, Michael Cheung, Amy Earley, Gowri Raman, Samuel A. Abariga, Martin Wagner, Ethan M. Balk - Kidney International 2009 cited by 1,733

  7. Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants

    Authors: Sindhu Chandran, Qizhi Tang, Minnie Sarwal, Zoltán Lászik, Amy Putnam, Kyoungtae Lee, Joey Leung, V. Nguyen, Tara K. Sigdel, Erica Tavares, Joshua Yang, Marc K. Hellerstein, Mark Fitch, Jeffrey A. Bluestone, Flavio Vincenti - American Journal of Transplantation 2017 cited by 219

  8. Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation

    Authors: Julio Pascual, Stefan P. Berger, Oliver Witzke, Hélio Tedesco‐Silva, Shamkant Mulgaonkar, Yasir Qazi, Steven J. Chadban, Federico Oppenheimer, Claudia Sommerer, Rainer Oberbauer, Yoshihiko Watarai, Christophe Legendre, Franco Citterio, Mitchell L. Henry, Titte R. Srinivas, Wen‐Lin Luo, AnaMaria Marti, Peter Bernhardt, Flavio Vincenti, on behalf of the TRANSFORM Investigators - Journal of the American Society of Nephrology 2018 cited by 244

  9. A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis

    Authors: Flavio Vincenti, Fernando C. Fervenza, Kirk N. Campbell, Montserrat Díaz, Loreto Gesualdo, Peter J. Nelson, Manuel Praga, Jai Radhakrishnan, Lorenz Sellin, Ajay Singh, Denyse Thornley‐Brown, Francisco Veríssimo Veronese, Beverly Accomando, Sara Engstrand, Steven Ledbetter, Julie Lin, John F. Neylan, James A. Tumlin - Kidney International Reports 2017 cited by 134

  10. Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus

    Authors: Flavio Vincenti, S. Friman, Ernst‐Heinrich Scheuermann, Lionel Rostaing, Trond Jenssen, Josep M. Campistol, Kazuharu Uchida, Mark D. Pescovitz, Piero Marchetti, Murat Tuncer, Franco Citterio, Andrzej Więcek, Steven J. Chadban, M. El-Shahawy, Klemens Budde, Norihiko Goto - American Journal of Transplantation 2007 cited by 617

  11. Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)

    Authors: Antoine Dürrbach, JO Medina Pestana, Thomas C. Pearson, Flavio Vincenti, Valter Duro Garcı́a, Josep M. Campistol, María del Carmen Rial, Sander Florman, A. Jay Block, G. Russo, J. Xing, Pushkal Garg, Josep M. Grinyó - American Journal of Transplantation 2010 cited by 565

  12. Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study

    Authors: Stefan P. Berger, Claudia Sommerer, Oliver Witzke, Hélio Tedesco‐Silva, Steven J. Chadban, Shamkant Mulgaonkar, Yasir Qazi, Johan W. de Fijter, Federico Oppenheimer, Josep M. Cruzado, Yoshihiko Watarai, P. Massari, Christophe Legendre, Franco Citterio, Mitchell L. Henry, Titte R. Srinivas, Flavio Vincenti, Maria Pilar Hernandez Gutierrez, Ana Maria Marti, Peter Bernhardt, Julio Pascual - American Journal of Transplantation 2019 cited by 149

  13. Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant

    Authors: Flavio Vincenti, Oriol Bestard, Amarpali Brar, Josep M. Cruzado, Daniel Serón, A. Osama Gaber, Nicole Ali, Anat R. Tambur, Helen Lee, Giovanni Abbadessa, Jo-Anne Paul, Markus Dudek, Ruby J. Siegel, Alba Torija, Dorothée Sémiond, Lucie Lépine, Nils Ternès, Robert A. Montgomery, Mark D. Stegall - Journal of the American Society of Nephrology 2023 cited by 32

  14. A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis

    Authors: Howard Trachtman, Fernando C. Fervenza, Debbie S. Gipson, Peter Heering, David Jayne, Harm Peters, Stefano Rota, Giuseppe Remuzzi, Lars Christian Rump, Lorenz Sellin, Jeremy P.W. Heaton, James B. Streisand, Marjie Hard, Steven Ledbetter, Flavio Vincenti - Kidney International 2011 cited by 258

  15. The kSORT Assay to Detect Renal Transplant Patients at High Risk for Acute Rejection: Results of the Multicenter AART Study

    Authors: Silke Roedder, Tara K. Sigdel, Nathan Salomonis, Sue Hsieh, Hong Dai, Oriol Bestard, Diana Metes, Andrea Zeevi, Albin Gritsch, Jennifer A. Cheeseman, Camila Macedo, Ram Peddy, Mara Medeiros-Domingo, Flavio Vincenti, Nancy Asher, Oscar Salvatierra, Ron Shapiro, Allan D. Kirk, Elaine Reed, Minnie Sarwal - PLoS Medicine 2014 cited by 181

  16. Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial

    Authors: Josep M. Grinyó, María del Carmen Rial, Josefina Alberú, Steven M. Steinberg, Roberto Ceratti Manfro, Georgy Nainan, Flavio Vincenti, Charlotte Jones-Burton, Nassim Kamar - American Journal of Kidney Diseases 2016 cited by 109

  17. Interleukin-6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: A randomized controlled trial

    Authors: Sindhu Chandran, Joey Leung, Crystal Hu, Zoltán Lászik, Qizhi Tang, Flavio Vincenti - American Journal of Transplantation 2020 cited by 69

  18. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

    Authors: Atul Humar, Y Lebranchu, Flavio Vincenti, Emily A. Blumberg, Jeffrey D. Punch, Ajit P. Limaye, Daniel Abramowicz, Alan G. Jardine, Athina Voulgari, J. Ives, I.A. Hauser, Patrick Peeters - American Journal of Transplantation 2010 cited by 499

  19. Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant

    Authors: Robert R. Redfield, Stanley C. Jordan, Stéphan Busque, Flavio Vincenti, E. Steve Woodle, Niraj M. Desai, Elaine F. Reed, Simon Tremblay, Andrea A. Zachary, Ashley Vo, Richard N. Formica, Thomas H. Schindler, Ha Tran, Caroline Looney, Candice Jamois, Cherie Green, Alyssa Morimoto, Richa Rajwanshi, Aaron Schroeder, Matthew D. Cascino, Paul Brunetta, Dominic Borie - American Journal of Transplantation 2019 cited by 79

  20. AN OPEN-LABEL, CONCENTRATION-RANGING TRIAL OF FK506 IN PRIMARY KIDNEY TRANSPLANTATION

    Authors: David A. Laskow, Flavio Vincenti, John F. Neylan, Robert Mendez, Arthur J. Matas - Transplantation 1996 cited by 221

  21. Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study

    Authors: Atul Humar, Ajit P. Limaye, Emily A. Blumberg, Ingeborg A. Hauser, Flavio Vincenti, Alan G. Jardine, Daniel Abramowicz, Jane Ives, Mahdi Farhan, Patrick Peeters - Transplantation 2010 cited by 208

  22. Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant Recipients

    Authors: Lionel Rostaing, P. Massari, Valter Duro Garcı́a, Eduardo Mancilla-Urrea, Georgy Nainan, María del Carmen Rial, Steven Steinberg, Flavio Vincenti, Rebecca Shi, Greg Di Russo, Dolca Thomas, Josep M. Grinyó - Clinical Journal of the American Society of Nephrology 2010 cited by 185

  23. Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation study

    Authors: Marc Raynaud, Solaf Al Awadhi, Ivana Jurić, Gillian Divard, Yannis Lombardi, Nikolina Bašić‐Jukić, Olivier Aubert, Laurence Dubourg, Ingrid Masson, Christophe Mariat, Dominique Prié, Vincent Pernin, Moglie Le Quintrec, Timothy S. Larson, Mark D. Stegall, Boris Bikbov, Piero Ruggenenti, Laurent Mesnard, Hassan N. Ibrahim, Marie Bodilsen Nielsen, Arthur J. Matas, Brian J. Nankivell, Stan Benjamens, Robert A. Pol, Stephan J. L. Bakker, Xavier Jouven, Christophe Legendre, Nassim Kamar, Byron H. Smith, Hani M. Wadei, Antoine Dürrbach, Flavio Vincenti, Giuseppe Remuzzi, Carmen Lefaucheur, Andrew Bentall, Alexandre Loupy - BMJ 2023 cited by 37

  24. Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients

    Authors: Cary M. Looney, Aaron Schroeder, Erica Tavares, Jay Garg, Thomas H. Schindler, Flavio Vincenti, Robert R. Redfield, Stanley C. Jordan, Stéphan Busque, E. Steve Woodle, Jared Khan, Jeffrey Eastham, Sandrine Micallef, Cary D. Austin, Alyssa Morimoto - Transplantation Direct 2023 cited by 28